| Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab KA Thursky, LJ Worth, JF Seymour, H Miles Prince, MA Slavin British journal of haematology 132 (1), 3-12, 2006 | 215 | 2006 |
| Managing haematology and oncology patients during the COVID‐19 pandemic: interim consensus guidance R Weinkove, ZK McQuilten, J Adler, MR Agar, E Blyth, AC Cheng, ... Medical Journal of Australia 212 (10), 481-489, 2020 | 166 | 2020 |
| Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment IJ Abbott, MA Slavin, JD Turnidge, KA Thursky, LJ Worth Expert review of anti-infective therapy 9 (4), 471-488, 2011 | 155 | 2011 |
| Increasing incidence of Clostridium difficile infection, Australia, 2011–2012 C Slimings, P Armstrong, WD Beckingham, AL Bull, L Hall, KJ Kennedy, ... Medical Journal of Australia 200 (5), 272-276, 2014 | 148 | 2014 |
| Epidemiology of infections acquired in intensive care units JS Doyle, KL Buising, KA Thursky, LJ Worth, MJ Richards Seminars in respiratory and critical care medicine 32 (02), 115-138, 2011 | 144 | 2011 |
| Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia AR Tramontana, B George, AC Hurt, JS Doyle, K Langan, AB Reid, ... America 2, 4, 2010 | 139 | 2010 |
| Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools AB Reid, SCA Chen, LJ Worth Current opinion in infectious diseases 24 (6), 534, 2011 | 132 | 2011 |
| Impact of an integrated antibiotic allergy testing program on antimicrobial stewardship: a multicenter evaluation JA Trubiano, KA Thursky, AJ Stewardson, K Urbancic, LJ Worth, ... Clinical Infectious Diseases 65 (1), 166-174, 2017 | 131 | 2017 |
| Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy BW Teh, SJ Harrison, LJ Worth, T Spelman, KA Thursky, MA Slavin British journal of haematology 171 (1), 100-108, 2015 | 124 | 2015 |
| Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014 MM Chau, DCM Kong, SJ Van Hal, K Urbancic, JA Trubiano, ... Internal medicine journal 44 (12b), 1364-1388, 2014 | 116 | 2014 |
| Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices LJ Worth, JF Seymour, MA Slavin Supportive care in cancer 17 (7), 811-818, 2009 | 115 | 2009 |
| Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive Staphylococcus aureus surgical site infections: report from Australian … AL Bull, LJ Worth, MJ Richards Annals of surgery 256 (6), 1089-1092, 2012 | 113 | 2012 |
| Vancomycin‐resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high‐risk LJ Worth, KA Thursky, JF Seymour, MA Slavin European journal of haematology 79 (3), 226-233, 2007 | 106 | 2007 |
| A bundle of care to reduce colorectal surgical infections: an Australian experience A Bull, J Wilson, LJ Worth, RL Stuart, E Gillespie, B Waxman, W Shearer, ... Journal of Hospital Infection, 2011 | 101 | 2011 |
| Diminishing surgical site infections in Australia: time trends in infection rates, pathogens and antimicrobial resistance using a comprehensive Victorian surveillance program … LJ Worth, AL Bull, T Spelman, J Brett, MJ Richards infection control & hospital epidemiology 36 (4), 409-416, 2015 | 87 | 2015 |
| Use of empiric antimicrobial therapy in neutropenic fever CS Tam, M O'Reilly, D Andresen, S Lingaratnam, A Kelly, K Burbury, ... Internal Medicine Journal 41 (1b), 90-101, 2011 | 87 | 2011 |
| An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital LJ Worth, MJ Dooley, JF Seymour, L Mileshkin, MA Slavin, KA Thursky British journal of cancer 92 (5), 867-872, 2005 | 85 | 2005 |
| Central line–associated bloodstream infection in children: an update on treatment J Wolf, N Curtis, LJ Worth, PM Flynn The Pediatric infectious disease journal 32 (8), 905-910, 2013 | 84 | 2013 |
| Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation AP Ng, L Worth, L Chen, JF Seymour, HM Prince, M Slavin, K Thursky haematologica 90 (12), 1672-1679, 2005 | 79 | 2005 |
| An effective strategy for influenza vaccination of healthcare workers in Australia: experience at a large health service without a mandatory policy K Heinrich-Morrison, S McLellan, U McGinnes, B Carroll, K Watson, ... BMC infectious diseases 15, 1-8, 2015 | 75 | 2015 |
monica slavinPeterMacCallum Cancer and Royal Melbourne HospitalVerified email at petermac.org
